PROCEPT BioRobotics Q4 revenue $10.1M (+216% YoY); guides FY2022 revenue $54-58M

PROCEPT BioRobotics Corp

Revenue $10.1M in Q4 2021, up from $3.2M YoY; full year $34.5M vs $7.7M.
U.S. system/rental revenue $5.0M (Q4) vs $1.2M; handpiece/consumables $3.4M vs $0.8M.
Net loss widened to $18.3M in Q4 from $15.3M; full year loss $59.9M vs $53.0M.
Guides Q1 2022 revenue $12-12.5M; FY2022 revenue $54-58M, gross margin 47-49%, adj. EBITDA loss $60-63M.
Positive 5-year WATER Study data announced Feb 2022; sales force doubled.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.